|
Market Closed -
BURSA MALAYSIA
12:50:01 30/12/2025 +04
|
5-day change | 1st Jan Change | ||
| 0.2500 MYR | +21.95% |
|
-.--% | - |
| 04-30 | Supergenics Berhad Auditor Raises 'Going Concern' Doubt | CI |
| 02-27 | Supergenics Berhad Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Company Valuation: Supergenics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 27.44 | 26.04 | 27.44 | 24.77 | 69.41 | 29.11 |
| Change | - | -5.08% | 5.36% | -9.71% | 180.21% | -58.07% |
| Enterprise Value (EV) 1 | 29.58 | 29.55 | 32.12 | 26.86 | 73.89 | 32.5 |
| Change | - | -0.1% | 8.69% | -16.38% | 175.13% | -56.01% |
| P/E | -12.7x | 1,284x | 79.3x | 123x | -9.45x | -8.61x |
| PBR | 5.03x | 4.76x | 5.44x | 2.85x | 21x | 250x |
| PEG | - | -13x | 0x | -2.5x | 0x | 0.2x |
| Capitalization / Revenue | 5.34x | 2.37x | 2.56x | 2.42x | 13x | 5.17x |
| EV / Revenue | 5.76x | 2.69x | 3x | 2.62x | 13.9x | 5.78x |
| EV / EBITDA | -16.7x | 26.7x | 18.3x | 12.5x | -11.1x | -14.4x |
| EV / EBIT | -14.7x | 63.9x | 27.2x | 17.5x | -10x | -10.5x |
| EV / FCF | -15.7x | -28.3x | -38.7x | -183x | -54.1x | 19.2x |
| FCF Yield | -6.39% | -3.54% | -2.58% | -0.55% | -1.85% | 5.21% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0232 | 0.000218 | 0.003718 | 0.001876 | -0.0635 | -0.029 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 5.135 | 10.99 | 10.72 | 10.24 | 5.322 | 5.625 |
| EBITDA 1 | -1.769 | 1.107 | 1.752 | 2.148 | -6.675 | -2.264 |
| EBIT 1 | -2.013 | 0.4625 | 1.181 | 1.534 | -7.357 | -3.107 |
| Net income 1 | -2.15 | 0.0203 | 0.3458 | 0.1769 | -7.281 | -3.366 |
| Net Debt 1 | 2.147 | 3.512 | 4.684 | 2.084 | 4.477 | 3.394 |
| Reference price 2 | 0.2950 | 0.2800 | 0.2950 | 0.2300 | 0.6000 | 0.2500 |
| Nbr of stocks (in thousands) | 93,000 | 93,000 | 93,000 | 107,706 | 115,689 | 116,430 |
| Announcement Date | 30/04/21 | 29/04/22 | 28/04/23 | 30/04/24 | 30/04/25 | 30/04/26 |
1MYR in Million2MYR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 7.21M | |
| 34.78x | 6.2x | 18.42x | 0.92% | 51.61B | |
| -21.47x | 297.59x | -22.09x | -.--% | 44.89B | |
| 33.46x | 3.25x | 14.02x | -.--% | 42.77B | |
| 49.05x | 5.7x | 31.17x | -.--% | 42.58B | |
| 29.21x | 8.45x | 21.35x | 0.39% | 31.82B | |
| 35.3x | 5.79x | 26.33x | -.--% | 17.33B | |
| 24.28x | 2.11x | 9.13x | 1.11% | 14.76B | |
| 78.97x | 4.14x | 16.07x | -.--% | 14.09B | |
| Average | 32.95x | 41.65x | 14.30x | 0.3% | 28.87B | |
| Weighted average by Cap. | 28.33x | 55.88x | 13.02x | 0.29% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 03033 Stock
- Valuation Supergenics
Select your edition
All financial news and data tailored to specific country editions
